Advanced Search

 

Study ID Status Title Patient Level Data
NUC30935 Completed A Randomised, Multicenter, Placebo-Controlled Study to Assess the Efficacy and Optimal Duration of Lamivudine Treatment in Patients with Pre-core Mutant HBV Study Listed on ClinicalStudyDataRequest.com
NUC40040 Completed An Extended, Observational Study in Pediatric Patients with Chronic Hepatitis B Who Have Previously Received Long-Term Lamivudine Treatment Study Listed on ClinicalStudyDataRequest.com
NUCA3016 Completed A Five Year Final Study Report for NUCA/B3016 - A Long-Term Epidemiologic Study of Subjects Who Have Evidence of Possible Durable Response to Lamivudine in Phase II or Phase III Trials of Lamivudine
NUCB3017 Completed A Study of Extended Lamivudine Treatment for Hepatitis B Subjects Previously Enrolled in Phase II or Phase III Lamivudine Trials.
NUCB3018 Completed A Follow-On Study to Determine the Safety and Efficacy of Long-Term Lamivudine Treatment in Patients with Chronic Hepatitis B Infection (5 Year Treatment Plus 6 Months Off-treatment Follow-Up) Study Listed on ClinicalStudyDataRequest.com
NUCB3026 Completed A Double-Blind, Placebo-Controlled Study Of Lamivudine In Subjects In China With Chronic Hepatitis B Infection Followed By Long-Term (5 Years) Lamivudine Treatment Study Listed on ClinicalStudyDataRequest.com
NUCB4006 Completed A Double-blind Placebo Controlled Clinical End-points Trial of Lamivudine in Patients with Hepatitis B Related Cirrhosis Study Listed on ClinicalStudyDataRequest.com
ODS10005 Completed
OFA110867 Completed Clinical phase I/IIA study of subcutaneously administration of Ofatumumab in Rheumatoid Arthritis patients on stable dose Methotrexate
OM5 program (Reliant) Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Omacor Therapy in Hypertriglyceridemic Subjects Treated with Antara, followed by an 8-week extension Study Listed on ClinicalStudyDataRequest.com
OM5 program (Reliant) Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Omacor Therapy in Hypertriglyceridemic Subjects Treated with Antara, followed by an 8-week extension Study Listed on ClinicalStudyDataRequest.com
OM6 program (Reliant) Completed A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Combined Omacor and Simvastatin Therapy in Hypertriglyceridemic Subjects Study Listed on ClinicalStudyDataRequest.com
OM8 Afib Completed A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Lovaza for the Prevention of Recurrent, Symptomatic Atrial Fibrillation Study Listed on ClinicalStudyDataRequest.com
OM9L Completed A Randomized, Double-Blind, Placebo-Controlled, Forced Titration Study to Assess the Efficacy and Safety of Omacor, Co-Administered with Open-Label Atorvastatin Therapy, in Hypertriglyceridemic Subjects Study Listed on ClinicalStudyDataRequest.com
OMB110911 Active, Not Recruiting A phase III, open label, randomized, multicenter trial of Ofatumumab added to Chlorambucil versus Chlorambucil Monotherapy in previously untreated patients with Chronic Lymphocytic Leukemia
OMB111148 Completed An open-label phase I study of ofatumumab (GSK1841157) in Japanese patients with CD20 positive follicular lymphoma or chronic lymphocytic leukemia
PCR111656 Completed An open-label, randomized, single dose, two-period crossover study to demonstrate bioequivalence between the controlled release paroxetine tablet (37.5 mg) manufactured at Cidra and Mississauga Study Listed on ClinicalStudyDataRequest.com
PE-01 Completed A randomized double-blind placebo-controlled study to evaluate the inhibitory effect against the onset of influenza virus-infected pateients Study Listed on ClinicalStudyDataRequest.com
PIK111051 Terminated A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK1059615 in Patients with Solid Tumors or Lymphoma Study Listed on ClinicalStudyDataRequest.com
PLK107427 Completed A Phase I Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of [GSK461364], a Polo-like Kinase 1 (PLK1) Inhibitor, in Adult Subjects with Advanced Solid Tumor or Non-Hodgkins Lymphoma Study Listed on ClinicalStudyDataRequest.com
PM1106502 Completed A randomized, single blind, repeat dose, placebo-controlled, single-period, parallel group study to investigate the safety, tolerability and potential pharmacokinetic interactions between GW856553 and Rosuvastatin (10mg), when co-administered in healthy adult male subjects
PM1108357 Completed A Double-Blind, Placebo-Controlled, Parallel Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.
PM1111138 Completed A double-blind, placebo-controlled, parallel group study to evaluate the effects of two regimens of GW856553, over a period of 3 month, on in-vivo macrophage activity, as assessed by FDG-PET/CT imaging, in the carotid arteries and aorta of subjects with established atherosclerosis Study Listed on ClinicalStudyDataRequest.com
POP5108 Completed A repeated dose pharmacokinetic study in healthy volunteers to compare 1.5 mg of fondaparinux sodium in subjects with a low (35 to 50 kg) body weight (LBW) to 2.5 mg of fondaparinux sodium in subjects with standard (60 to 100 kg) body weight (SBW)
RA4104917 Completed A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety, tolerability, pharmacokinetics and effect on synovial thickness and vascularity of 28 days repeat dosing of GW274150 or 7.5mg prednisolone in RA subjects. Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.